N. Firth et al.
2014; 9: 321–327.
62. Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L,
Lewczuk P, Stiefel M, et al. Erythropoietin therapy for
acute stroke is both safe and beneficial. Mol Med 2002;
8: 495–505.
63. Grade C, Redford B, Chrostowski J, Toussaint L, Blackwell
B. Methylphenidate in early poststroke recovery: a double-
blind, placebo-controlled study. Arch Phys Med Rehabil
1998; 79: 1047–1050.
64. Schaebitz WR, Laage R, Vogt G, Koch W, Kollmar R, Schwab
S, et al. AXIS A Trial of intravenous granulocyte colony-
stimulating factor in acute ischemic stroke. Stroke 2010;
41: 2545–2551.
65. Kwakkel G, Lannin NA, Borschmann K, English C, Ali M,
Churilov L, et al. Standardized measurement of sensorimo-
tor recovery in stroke trials: consensus-based core recom-
mendations from the Stroke Recovery and Rehabilitation
Roundtable. Int J Stroke 2017; 12: 451–461.
66. Walker MF, Hoffmann TC, Brady MC, Dean CM, Eng JJ,
Farrin AJ, et al. Improving the development, monitoring
and reporting of stroke rehabilitation research: consensus-
based core recommendations from the Stroke Recovery and
Rehabilitation Roundtable. Int J Stroke 2017; 12: 472–479.
67. Micromedex® 2.0. Truven Health Analytics. 2017 [cited
2017 Mar 30]. Available from: http://www.micromedexso-
lutions.com.elibrary.jcu.edu.au/.
68. Mead G, Hackett ML, Lundström E, Murray V, Hankey GJ,
Dennis M. The FOCUS, AFFINITY and EFFECTS trials stu-
dying the effect(s) of fluoxetine in patients with a recent
stroke: a study protocol for three multicentre randomised
330
www.medicaljournals.se/jrm
controlled trials. Trials 2015; 16: 369.
69. Dennis M, Mead G, Forbes J, Graham C, Hackett M, Han-
key GJ, et al. Effects of fluoxetine on functional outcomes
after acute stroke (FOCUS): a pragmatic, double-blind,
randomised, controlled trial. Lancet 2019; 393: 265–274.
70. Anon C. ICH S7A: safety pharmacology studies for human
pharmaceuticals. London: The European Agency for the
Evaluation of Medicinal Products Evaluation of Medicines
for Human Use CPMP/ICH/539/00; 2000, p. 1–9.
71. Névéol A, Doğan RI, Lu Z. Author keywords in biomedical
journal articles. AMIA Annual Symposium proceedings
AMIA Symposium 2010; 2010: 537–541.
72. Corbett D, Carmichael ST, Murphy TH, Jones TA, Schwab
ME, Jolkkonen J, et al. Enhancing the alignment of the
preclinical and clinical stroke recovery research pipeline:
consensus-based core recommendations from the Stroke
Recovery and Rehabilitation Roundtable translational wor-
king group. Int J Stroke 2017; 12: 462–471.
73. van Vliet P, Hunter SM, Donaldson C, Pomeroy V. Using
the TIDieR Checklist to standardize the description of a
functional strength training intervention for the upper
limb after stroke. J Neurol Phys Ther 2016; 40: 203–208.
74. Schulz KF, Altman DG, Moher D. CONSORT 2010 State-
ment: updated guidelines for reporting parallel group
randomised trials. BMJ 2010; 340: c332.
75. Australian Medicines Handbook 2017. Australian Medicines
Handbook Pty Ltd; 2017. Available from: https://amhon-
line.amh.net.au/.
76. eTG complete 2018. West Melbourne, VIC, Australia: Th-
erapeutic Guidelines Ltd; 2018.